ES2052201T3 - Esteres retinoicos de l-cladinosa, su procedimiento de preparacion y su utilizacion en medicina humana o veterinaria y en cosmetica. - Google Patents

Esteres retinoicos de l-cladinosa, su procedimiento de preparacion y su utilizacion en medicina humana o veterinaria y en cosmetica.

Info

Publication number
ES2052201T3
ES2052201T3 ES90400723T ES90400723T ES2052201T3 ES 2052201 T3 ES2052201 T3 ES 2052201T3 ES 90400723 T ES90400723 T ES 90400723T ES 90400723 T ES90400723 T ES 90400723T ES 2052201 T3 ES2052201 T3 ES 2052201T3
Authority
ES
Spain
Prior art keywords
cosmetics
human
veterinary medicine
cladinose
preparation procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90400723T
Other languages
English (en)
Inventor
Michel Philippe
Henri Sebag
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of ES2052201T3 publication Critical patent/ES2052201T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)

Abstract

ESTERES RETINOICOS DE L-CLADINOSA. ESTOS ESTERES RESPONDEN A LA FORMULA GENERAL (I), EN LA QUE EL RADICAL R1-CO REPRESENTA EL RADICAL RETINOILO (TRANS) O (13 CIS) O EL RADICAL ETRETINOILO, Y R2 ES UN RADICAL ALQUILO, LINEAL O RAMIFICADO, QUE TIENE DE 1-24 ATOMOS DE CARBONO, Y LOS ANOMEROS (ALFA) Y (BETA) Y SUS MEZCLAS. USO EN MEDICINA HUMANA Y VETERINARIA Y EN COSMETICA.
ES90400723T 1989-03-16 1990-03-16 Esteres retinoicos de l-cladinosa, su procedimiento de preparacion y su utilizacion en medicina humana o veterinaria y en cosmetica. Expired - Lifetime ES2052201T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8903461A FR2644459B1 (fr) 1989-03-16 1989-03-16 Esters retinoiques de l-cladinose, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique

Publications (1)

Publication Number Publication Date
ES2052201T3 true ES2052201T3 (es) 1994-07-01

Family

ID=9379762

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90400723T Expired - Lifetime ES2052201T3 (es) 1989-03-16 1990-03-16 Esteres retinoicos de l-cladinosa, su procedimiento de preparacion y su utilizacion en medicina humana o veterinaria y en cosmetica.

Country Status (8)

Country Link
US (1) US5096713A (es)
EP (1) EP0388314B1 (es)
JP (1) JPH02268193A (es)
AT (1) ATE105563T1 (es)
CA (1) CA2012218A1 (es)
DE (1) DE69008762T2 (es)
ES (1) ES2052201T3 (es)
FR (1) FR2644459B1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703130A (en) * 1995-06-07 1997-12-30 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Chalcone retinoids and methods of use of same
US5716982A (en) * 1995-06-07 1998-02-10 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Retinoids and methods of use of same
US5968940A (en) * 1995-06-08 1999-10-19 Institute Of Materia Medica Retinoids and methods of use of same
FR2735694B1 (fr) * 1995-06-20 1997-08-08 Roussel Uclaf Le cladinose a titre de medicament et les compositions pharmaceutiques les renfermant
US20050239749A1 (en) * 2002-07-25 2005-10-27 Lion Corporation External preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984544A (en) * 1975-02-28 1976-10-05 Schering Corporation Retinoic acid esters of steroids of the pregnane series, their use in the treatment of acne and pharmaceutical formulations useful therefor
US4108880A (en) * 1975-11-03 1978-08-22 Johnson & Johnson Esters of retinoic acid
US4216224A (en) * 1978-09-22 1980-08-05 Scott Eugene J Van Methods and compositions for treating psoriasis with retinoyl compounds
CH661516A5 (de) * 1983-12-08 1987-07-31 Hoffmann La Roche Phenylnonatetraenoylzuckerderivate.
KR950014443B1 (ko) * 1986-07-16 1995-11-28 엠. 클리그만 알버트 일광손상된 인체피부를 치료하기 위한 레티노이드를 함유하는 조성물
US4885311A (en) * 1987-06-29 1989-12-05 Molecular Design International Topical transretinoids for treatment of acne and skin diseases

Also Published As

Publication number Publication date
ATE105563T1 (de) 1994-05-15
FR2644459B1 (fr) 1994-10-28
JPH02268193A (ja) 1990-11-01
US5096713A (en) 1992-03-17
DE69008762D1 (de) 1994-06-16
DE69008762T2 (de) 1994-08-25
EP0388314B1 (fr) 1994-05-11
FR2644459A1 (fr) 1990-09-21
EP0388314A1 (fr) 1990-09-19
CA2012218A1 (fr) 1990-09-16

Similar Documents

Publication Publication Date Title
ES2081054T3 (es) Composicion cosmetica.
ES2038627T3 (es) Derivados del acido (met)-acrilico que contienen grupos uretano.
BR8705931A (pt) Ventilador que ministra respiracao artificial a um paciente
ES2022610B3 (es) Compuestos para potenciar la permeabilidad de la piel que utilizan esteres de sacarosa.
IT1256248B (it) Formulazioni iniettabili acquose per radiodiagnostica comprendenti miscele di composti aromatici iodurati utili come agenti opacizzanti ai raggi x
IT8648230A0 (it) Unghia finta o artificiale ad applicazione perfezionata all'unghia naturale
ES2070244T3 (es) Preparado de hypericina.
ES2048109B1 (es) Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
IT1181642B (it) Composti di fenetanolammina come stimolanti in medicina e procedimento per prepararli
ATE43066T1 (de) Kosmetische zusammensetzung fuer die hautpflege.
ES2053926T3 (es) Colorantes indol-aldehido para el cabello.
IT8767392A0 (it) Procedimento di tintura di capelli umani con la brasilina o suoi derivati ossidrilati e composizioni utilizzate
BE828046A (fr) Systeme optique accroissant la quantite d'energie que peut fournir un laser
ES2110213T3 (es) Derivado de n-acilglutamina.
ES2159296T3 (es) Procedimiento para preparar 2,2-difluorocetena silil acetales y esteres de acido alfa,alfa-difluoro-beta-sililoxi-1,3-dioxolano-4-propanoico.
ES2118728T3 (es) Procedimiento para la preparacion de 2,3-piridindicarboxilatos sustituidos y no sustituidos a partir de cloromaleato o clorofumarato o sus mezclas.
ES2054650T3 (es) Fenilacetonitrilos basicamente substituidos, su obtencion y medicamentos que los contienen.
DOP1982004086A (es) Formula farmaceutica que comprende insulina humana y proinsulina humana
DK533785A (da) Fedtsyreestere til anvendelse i kosmetiske produkter og fremgangsmaade til fremstilling af saadanne estere
ATE121293T1 (de) Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält.
ES2052200T3 (es) Esteres retinoicos de d-desosamina, su procedimiento de preparacion y su utilizacion en medicina humana o veterinaria y en cosmetica.
ES8504179A1 (es) "procedimiento para preparar derivados de 1,4-dihidropiridina".
ES2046189T3 (es) Derivados de dihidropiridina y composiciones de los mismos.
IT1132065B (it) Fosforo alluminato emettitore di raggi ultravioletti e lampade fluorescenti per l'abbronzatura artificiale utilizzanti tale fosforo
DE69008762D1 (de) Retinsäureester von l-Cladinos, Verfahren zu deren Herstellung und ihre Verwendung in der Human- oder Veterinärmedizin und in der Kosmetik.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 388314

Country of ref document: ES